Can antidepressants prevent pegylated interferon-α/ribavirin-associated depression in patients with chronic hepatitis C: meta-analysis of randomized, double-blind, placebo-controlled trials?

PloS one

Volumn 8, Issue 10, 2013, Pages

  Hou, Xin Jiang ^a   Xu, Jing Hang ^b   Wang, Jun ^b   Yu, Yan Yan ^b  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIDEPRESSANT AGENT; ANTIVIRUS AGENT; CITALOPRAM; MACROGOL DERIVATIVE; PAROXETINE; RIBAVIRIN;

ARTICLE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DEPRESSION; DOUBLE BLIND PROCEDURE; HEPATITIS C; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; ANTIVIRAL AGENTS; CITALOPRAM; DEPRESSION; DOUBLE-BLIND METHOD; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; PAROXETINE; POLYETHYLENE GLYCOLS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RIBAVIRIN; TREATMENT OUTCOME;

EID: 84905012612     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076799     Document Type: Article

References (0)